Belgium· BE-AMP-SAM498933-00
Caspofungin Sandoz 50 mg
A caspofungin product containing caspofungin acetate, registered in Belgium by Sandoz. The same ATC class is registered in 18 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Caspofungin is registered in 18 of 19 countries.
Countries holding a registration under ATC J02AX04 (caspofungin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 10 of them publish a price we can compare per daily dose
Caspofungin · ATC J02AX04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of caspofungin costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Caspofungin · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$358.98
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Caspofungin Acetate
- Manufacturer
- Sandoz
- Country
- Belgium (BE)
- ATC code
- J02AX04
- ATC class
- Caspofungin
- Defined daily dose
- 50 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb7718356
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
112 interactions on record for caspofungin.
Graded by severity as the source publishes them — 6 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Caspofungin · interactions on record
112 records
- 6 severe
- 35 moderate
- 71 info
Most severe, free to view
- DexamethasoneH02AB02severe
- LeflunomidL04AA13severe
- TeriflunomidL04AA31severe
- LeflunomideL04AK01severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Caspofungin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SpainCANCIDAS 50 mg POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSIONMerck Sharp & Dohme B.V.
- FinlandCancidasMerck Sharp & Dohme B.V.
- United KingdomCancidas 50mg powder for concentrate for solution for infusion vialsMerck Sharp & Dohme (UK) Ltd
- SwedenCancidas 50 mg Pulver till infusionsvätska, lösningMerck Sharp & Dohme Limited
- PolandCancidasMerck Sharp & Dohme B.V.
- IrelandCancidas 50 mg powder for concentrate for solution for infusionMerck Sharp & Dohme BV
- IcelandCancidasMerck Sharp & Dohme B.V.*
- NorwayCancidasMerck Sharp & Dohme B.V. (1)
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Caspofungin Anfarm, Caspofungin Fresenius Kabi
- Bulgaria · Каспофунгин Ромфарм
- Cyprus · Caspofungin Demo, Caspofungin Sapiens
- Czechia · Caspofungin Demo
- Germany · Caspofungin Demo, Caspofungin Eberth
- Denmark · Casmyg, Caspofungin "sandoz"
- Estonia · Caspofungin Sandoz
- Spain · Caspofungin Demo, Caspofungina Demo
- Finland · Caspofungin Demo S.A., Caspofungin Lorien
- France · Caspofungine Hikma, Caspofungine Lorien
- United Kingdom (Northern Ireland) · Caspofungin, Caspofungin Demo Pharmaceutical Industry
- Greece · Casmyg, Caspofungin Anfarm
- Croatia · Dalvocans, Kaspofungin Ligula Pharma
- Hungary · Caspofungin Demo, Caspofungin Onkogen
- Ireland · Caspofungin, Caspofungin Clonmel
- Iceland · Cancidas, Caspofungin Stada
- Italy · Caspofungi Hikma, Caspofungin Demo
- Liechtenstein · Cancidas
- Lithuania · Caspofungin Sandoz
- Luxembourg · Caspofungine Noridem
- Latvia · Caspofungin Pharmidea
- Malta · Caspofungin Anfarm, Caspofungin Centrient Pharmaceutcials Netherlands
- Netherlands · Caspofungine Cf, Caspofungine Demo
- Norway · Cancidas, Caspofungin Demo S.A.
- Poland · Caspofungin Adamed, Caspofungin Demo
- Portugal · Caspofungina Farmoz, Caspofungina Generis
- Romania · Caspofungină Demo, Caspofungină Kabi
- Sweden · Caspofungin Demo S.A., Caspofungin Fresenius Kabi
- Slovenia · Kaspofungin, Kaspofungin Teva
- Slovakia · Caspofungin Demo, Caspofungin Sandoz
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d5f1a632-4f15-4e9a-959a-923d57283cff GET /v1/drugs/d5f1a632-4f15-4e9a-959a-923d57283cff?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Powder for concentrate for solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Caspofungin Sandoz 50 mg",
"name_fr": "Caspofungin Sandoz 50 mg",
"name_nl": "Caspofungin Sandoz 50 mg",
"amp_code": "SAM498933-00",
"strengths": [
"55.4500",
"50.0000"
],
"pack_count": 1,
"substances": [
"Caspofungin Acetate",
"Caspofungin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Caspofungin",
"authorisation_numbers": [
"BE498933"
]
}See everything about caspofungin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.